BioCryst Pharmaceuticals, Inc. (BMV:BCRX)
Mexico flag Mexico · Delayed Price · Currency is MXN
148.50
0.00 (0.00%)
At close: Mar 2, 2026

BioCryst Pharmaceuticals Ratios and Metrics

Millions MXN. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
37,75329,56632,45720,74041,74651,090
Upgrade
Market Cap Growth
-4.83%-8.91%56.49%-50.32%-18.29%95.19%
Upgrade
Enterprise Value
41,35038,03143,12828,31147,49953,366
Upgrade
Last Close Price
148.50159.50155.00113.92215.00255.00
Upgrade
PE Ratio
7.956.22----
Upgrade
PS Ratio
2.401.883.463.707.9015.86
Upgrade
PB Ratio
-17.60-13.78-3.27-2.69-7.26-23.29
Upgrade
P/FCF Ratio
6.084.76----
Upgrade
P/OCF Ratio
6.044.73----
Upgrade
EV/Sales Ratio
2.662.424.595.058.9916.56
Upgrade
EV/EBITDA Ratio
6.606.021194.32---
Upgrade
EV/EBIT Ratio
6.716.08----
Upgrade
EV/FCF Ratio
6.666.13----
Upgrade
Debt / Equity Ratio
-4.01-4.01-1.77-1.86-2.52-5.54
Upgrade
Debt / EBITDA Ratio
1.351.35208.58---
Upgrade
Debt / FCF Ratio
1.381.38----
Upgrade
Net Debt / Equity Ratio
-1.70-1.70-1.09-1.01-1.08-0.80
Upgrade
Net Debt / EBITDA Ratio
0.580.58300.39-4.79-2.17-0.48
Upgrade
Net Debt / FCF Ratio
0.590.59-9.79-4.72-1.94-0.59
Upgrade
Asset Turnover
1.741.740.900.620.480.34
Upgrade
Inventory Turnover
26.8326.8310.107.7012.0018.93
Upgrade
Quick Ratio
1.951.952.492.974.505.18
Upgrade
Current Ratio
2.062.062.633.314.895.46
Upgrade
Return on Assets (ROA)
43.21%43.21%-0.16%-11.57%-16.30%-24.07%
Upgrade
Return on Invested Capital (ROIC)
413.47%535.23%-5.24%-738.74%-24821.91%-
Upgrade
Return on Capital Employed (ROCE)
109.20%109.20%-0.40%-26.90%-33.40%-36.70%
Upgrade
Earnings Yield
12.58%16.07%-5.71%-18.47%-11.55%-7.39%
Upgrade
FCF Yield
16.45%21.00%-3.41%-7.93%-7.63%-5.80%
Upgrade
Buyback Yield / Dilution
-5.75%-5.75%-7.54%-3.38%-3.79%-7.08%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.